This Metal Injection Moulding Stock Rises 45% Since Listing: What Is Powering the Rally?

CMP approximately Rs 995.55 (11 Sep 2026). Since listing 45.14%, 1M 23.63%. IPO price Rs 485. 52W range Rs 700 to Rs 1,028.50. Q1 FY27 PAT Rs 240 Cr vs Rs 182 Cr.

This metal injection moulding stock has gained approximately 45.14% since it listed on the NSE on 30 July 2026, and 23.63% of that move came in just the last month. The one-month return ranks 4th among 101 large-cap and mid-cap NSE shares on our screen as of 10 September 2026, a rare feat for a company that has traded for only six weeks.

The company is INDO-MIM Ltd (NSE: INDOMIM), a precision engineering firm founded in 1996 that makes small, complex metal parts for automobiles, aircraft, defence equipment, medical devices and consumer products. The Indo-MIM share price opened near Rs 995.55 on Friday, 11 September 2026, down about 1.1% from the previous close of Rs 1,006.55, with a market capitalisation of approximately Rs 49,000 crore.

Click Here – Get Free Investment Predictions

How Much Has This Metal Injection Moulding Stock Returned Since Listing?

The short answer: about 45% since listing and about 24% in one month, on top of a strong debut premium over the IPO price. The IPO was priced at Rs 485 per share, at the top of the Rs 461 to Rs 485 band, and the shares opened at Rs 700 on the NSE on listing day. That debut alone was a premium of approximately 44%.

Because this metal injection moulding stock is new to the market, the screen shows the same 45.14% figure for the six-month, one-year, three-year and five-year windows. All of these simply capture the gain since listing, so this article labels the period as since listing. No stock split or bonus issue has taken place, which means the return reflects genuine price appreciation.

Measured from the Rs 485 issue price, the metal injection moulding stock has roughly doubled, turning a Rs 14,550 minimum application into about Rs 29,900. The 52-week range runs from Rs 700, the listing-day opening price, to a record high of Rs 1,028.50, so the metal injection moulding stock is trading about 3% below its peak.

What Is Metal Injection Moulding and Why Does It Matter?

Metal injection moulding mixes fine metal powder with a binder, injects it into a mould like plastic, and then sinters the part to near full density. The process can produce thousands of tiny, intricate components with tight tolerances at a lower cost than machining each one. That makes it popular for firearm triggers, surgical tool jaws, fuel system parts, aircraft brackets and phone components.

Indo-MIM claims the world’s largest installed capacity in this process and held about 6.8% of the global market, ranking first for six straight years through 2025. The metal injection moulding stock also offers investment casting, precision machining, ceramic injection moulding and 3D metal printing across 15 plants: six in India, six in the United States, two in the United Kingdom and one in Mexico. For anyone tracking a metal injection moulding stock, that scale is the main reason this metal injection moulding stock commands a premium.

Why Did This Metal Injection Moulding Stock Rise 45% Since Listing?

The rally rests on three pillars: heavy institutional demand in the IPO, a blowout June quarter, and scarcity value as the only listed global leader in its niche. Each of these pushed the metal injection moulding stock higher at a different stage of its short trading history.

1. Massive IPO Demand Set the Tone

The Rs 3,812 crore issue, made up of a Rs 501 crore fresh issue and a Rs 3,311 crore offer for sale, was subscribed approximately 72 times. Qualified institutional buyers bid about 204 times their quota, non-institutional investors about 51 times and retail investors about 6.7 times.

The company also raised about Rs 1,141 crore from anchor investors before the issue opened. Demand of this scale for a metal injection moulding stock usually signals that large funds wanted more shares than they received, and some of that unmet demand flowed into the metal injection moulding stock after listing.

2. Q1 FY27 Profit Jumped 32% and Margins Expanded

The biggest single trigger came on 18 August 2026, when the metal injection moulding stock hit a 10% upper circuit at Rs 951.30 after its first quarterly results as a listed company. Consolidated net profit rose 31.6% year on year to Rs 240.12 crore, from Rs 182.41 crore.

Revenue from operations grew a more modest 9.4% to approximately Rs 1,219 crore, but EBITDA climbed about 24% and the EBITDA margin widened by roughly four percentage points to about 33%. Sequentially, net profit surged about 73% from Rs 139 crore in the March quarter, which told the market that the weak Q4 was a blip rather than a trend for this metal injection moulding stock.

3. Scarcity Value and Export Exposure

About 77% of FY26 revenue came from exports, with North America contributing roughly 44%. Investors looking for Indian manufacturers that sell high-value parts to global OEMs have few options of this size, and the metal injection moulding stock fills that gap across automotive, aerospace, defence and medical markets.

The company served more than 1,100 customers and made over 6,400 products in FY26. That diversity in a metal injection moulding stock reduces dependence on any one industry cycle, a point that has supported the premium valuation of this metal injection moulding stock.

4. The Anchor Lock-In Passed Without a Sell-Off

Half of the anchor shares became free to trade on 27 August 2026. Many recent listings slip when lock-ins end, and a metal injection moulding stock with a small float could have been vulnerable too, but the metal injection moulding stock went on to set a new record high of Rs 1,028.50 afterwards. That resilience helped lift the one-month return to 23.63%, the 4th best on the 101-stock screen.

Check the Univest Screener for Live Fundamentals of High-Return Stocks

How Strong Are the Financials Behind This Metal Injection Moulding Stock?

The financial record of this metal injection moulding stock supports the story, though growth has not been a straight line. Revenue rose from approximately Rs 2,517 crore in FY22 to Rs 4,321 crore in FY26, a gain of about 72%. Net profit, however, fell from Rs 598 crore in FY22 to Rs 284 crore in FY24 before recovering to Rs 534 crore in FY26.

FY26 revenue grew about 28% and net profit about 26%, while operating cash flow more than doubled to approximately Rs 1,077 crore. The table below shows the latest three reported quarters for the metal injection moulding stock.

The Q1 FY27 net margin of 19.70% is the best of the three quarters, and it came with lower expenses than the March quarter despite higher sales. Standalone operating margin improved to about 36% from 32%, which points to better product mix and cost control rather than one-off gains.

Balance sheet quality for the metal injection moulding stock is reasonable. Debt to equity stands at approximately 0.49, and Rs 400 crore of the fresh issue proceeds is earmarked for debt repayment, which should lower interest costs from FY27 onwards. Return on equity is around 20.9%.

Who Owns This Metal Injection Moulding Stock?

Promoters still control this metal injection moulding stock firmly. Green Meadows Investments Ltd alone holds about 76.31%, and the total promoter group stake is 77.65% after the IPO, down from 93.34% before the offer for sale.

Institutions together own just over 8%, which leaves room for fund buying if the company delivers. Several mutual fund schemes, including large and midcap and flexi cap funds, have already taken small positions. The free float is only about 22%, which can amplify moves in the metal injection moulding stock in both directions.

What Are the Key Risks for Indo-MIM Investors?

The metal injection moulding stock now trades at approximately 93 times trailing earnings, about double the industry PE of 46.33 and roughly twice the 45 times multiple at which the IPO was priced. A valuation this rich leaves little room for a weak quarter.

Export and currency risk: For a metal injection moulding stock with about 77% of revenue from exports and 44% from North America, a US slowdown, tariff changes or a sharply stronger rupee could hit growth and margins.

Lumpy earnings: Profits fell for two straight years between FY22 and FY24, and the March 2026 quarter showed a sharp dip. Revenue growth of 9.4% in Q1 FY27 was also slower than profit growth, so margin gains must hold.

Supply overhang: The remaining anchor shares unlock around 26 October 2026, and the promoter holds a large stake that could be diluted further over time to meet public shareholding norms. Either event can pressure the Indo-MIM share price in the short term.

Short trading history: With only about six weeks of price data, the metal injection moulding stock has not yet been tested through a broad market correction.

Download the Univest iOS App or Univest Android App to track the Indo-MIM share price live

Indo-MIM Share: Analyst View

Coverage of this metal injection moulding stock is still thin because it listed only in late July. Before the IPO, pre-issue notes on the metal injection moulding stock from domestic brokerages recommended subscribing at the Rs 485 issue price, citing global leadership, diversified end markets and a strong return profile.

After the August rally, an analyst at a domestic brokerage said the valuation looked demanding and already discounted a large part of future growth. The advice was that existing holders could stay invested for the long term, while new investors should wait for meaningful corrections before buying.

Indo-MIM Share Price Target

As of 11 September 2026, no verified post-listing Indo-MIM share price target from a brokerage is publicly available. The only published reference points are pre-IPO notes pegged at the Rs 485 issue price, which the Indo-MIM share price has already doubled past.

In the absence of a formal Indo-MIM share price target, traders of the metal injection moulding stock are watching the record high of Rs 1,028.50 as near-term resistance and the Rs 951.30 post-results circuit level as the first support. A sustained move above the high would put this metal injection moulding stock in fresh price discovery, while a break below Rs 951 could open a slide towards the Rs 860 zone seen before results.

Any future Indo-MIM share price target from analysts will likely hinge on whether the 33% EBITDA margin of Q1 FY27 can be sustained and whether revenue growth picks up from single digits.

Conclusion

This metal injection moulding stock has delivered approximately 45% since listing and 23.63% in the past month, powered by 72 times IPO demand, a 32% jump in Q1 FY27 profit and its position as the global leader in a specialised manufacturing niche. The Indo-MIM share price has roughly doubled from its IPO price in six weeks, one of the strongest IPO debuts of 2026.

The flip side is a PE of about 93, a small free float, heavy export exposure and an anchor unlock in October. Long-term investors may find the metal injection moulding stock compelling, but this metal injection moulding stock now needs consistent quarterly delivery to justify its price. Staggered entries and strict position sizing make more sense than chasing the rally.

Frequently Asked Questions

Which metal injection moulding stock has risen 45% since listing?

Ans. INDO-MIM Ltd (NSE: INDOMIM) is the metal injection moulding stock that has gained approximately 45.14% since listing on 30 July 2026, as of 10 September 2026. It also returned 23.63% in one month, ranking 4th among 101 NSE stocks screened.

What was the Indo-MIM IPO price and listing price?

Ans. The IPO was priced at Rs 485 per share, at the top of the Rs 461 to Rs 485 band. The shares opened at Rs 700 on the NSE on 30 July 2026, a listing premium of approximately 44%.

Why did the Indo-MIM share price rise so sharply?

Ans. The rise came from 72 times IPO subscription, a 31.6% jump in Q1 FY27 net profit to Rs 240.12 crore and margin expansion to about 33%. The stock hit a 10% upper circuit on 18 August 2026 after the results.

What were Indo-MIM Q1 FY27 results?

Ans. Revenue from operations rose 9.4% year on year to about Rs 1,219 crore, and EBITDA grew about 24%. Net profit increased 31.6% to Rs 240.12 crore, with the net margin reaching 19.70%.

What is the 52-week high and low of Indo-MIM?

Ans. Indo-MIM has a 52-week high of Rs 1,028.50, which is also its record high, and a low of Rs 700, its listing-day opening price. The stock traded near Rs 995.55 on 11 September 2026.

Is this metal injection moulding stock overvalued?

Ans. At approximately 93 times trailing earnings against an industry PE of 46.33, the valuation is demanding. The stock is pricing in sustained margin gains, so a weak quarter could trigger a sharp correction.

What is the Indo-MIM share price target?

Ans. No verified post-listing brokerage target is publicly available yet; pre-IPO notes were pegged at the Rs 485 issue price. Traders are tracking Rs 1,028.50 as resistance and Rs 951.30 as the first support.

Should I buy this metal injection moulding stock now?

Ans. After a near doubling from the IPO price, much optimism is already in the price, and an anchor lock-in expiry in October could add supply. Staggered buying with a clear stop loss is more prudent, and consulting a SEBI-registered advisor is recommended.